相关实验视频
Updated: May 13, 2025

10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
21.4K
血栓抗脂综合征:复发性血栓形成
T M Reshetnyak1,2, F A Cheldieva3, S I Glukhova3
1Nasonova Research Institute of Rheumatology, Moscow, Russia. t_reshetnyak@yahoo.com.
Doklady. Biochemistry and biophysics
|May 12, 2025
概括
抗脂综合征 (APS) 中的复发性血栓形成是常见的,特别是在三重IgG抗脂抗体 (aPL) 阳性和肥胖的情况下. 特定的IgG aPLs如IgG aCL,IgG aß2GP1,IgG aß2GP1-D1和IgG aPS/PT是关键的危险因素.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 类风湿病学 类风湿病学
背景情况:
- 抗脂综合征 (APS) 的特点是,在存在抗脂抗体 (aPL) 的情况下发生血栓栓塞事件.
- 了解复发性血栓形成及其在APS中的风险因素对于患者管理至关重要.
研究的目的:
- 评估APS患者中复发性血栓形成的发生率.
- 确定与APS中复发性血栓形成相关的风险因素.
主要方法:
- 对98名APS患者 (2014-2023) 的回顾性研究.
- 使用ELISA和CLA评估的抗脂抗体 (aPL),包括IgG/IgM aCL,IgG/IgM aß2GP1,IgG aß2GP1-D1,IgG/IgM aPS/PT等.
- 确定的血栓形成风险因素,包括肥胖.
主要成果:
- 血栓复发发生在63%的患者中.
- 直接口服抗凝剂 (DOAC) 与最高的复发率有关.
- 三重IgG aPL阳性 (IgG aCL,IgG aß2GP1,IgG aß2GP1-D1) 和IgG aPS/PT阳性是重要的风险因素.
- 肥胖增加了5倍的复发性血栓塞的风险.
结论:
- 在APS中,复发性血栓形成与特定的IgG aPLs (IgG aCL,IgG aß2GP1,IgG aß2GP1-D1,IgG aPS/PT) 密切相关.
- 在任何组合中,三重IgG aPL阳性显著增加了复发性血栓形成的风险.
- 肥胖是APS中复发性血栓形成的重要独立风险因素.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
546
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
546
Disorders of Hemostasis
647
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
647
Clot Retraction and Fibrinolysis
2.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
2.8K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
392
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
392
Extrinsic and Intrinsic Pathways of Hemostasis
4.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.0K
Blood Studies for Cardiovascular System III: Serum Lipid Profile
103
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
103

